Mohammed Masmudur Rahman

Person

Gainesville, FL, US

People

Patents Grantslast 30 patents

Information Patent Grant
Use of AAV-expressed M013 protein as an anti-inflammatory therapeutic
- Patent number 11,685,767
- Issue date Jun 27, 2023
- University of Florida Research Foundation, Incorporated
- Douglas Grant McFadden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oncolytic virus platform to treat cancers with myxoma virus
- Patent number 11,117,934
- Issue date Sep 14, 2021
- Arizona Board of Regents on behalf of Arizona State University
- Douglas Grant McFadden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
USE OF AAV-EXPRESSED M013 PROTEIN AS AN ANTI-INFLAMMATORY THERAPEUTIC
- Publication number 20240101607
- Publication date Mar 28, 2024
- University of Florida Research Foundation, Incorporated
- Douglas Grant McFadden
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ONCOLYTIC VIRUSES THAT EXPRESS MULTI-SPECIFIC IMMUNE CELL ENGAGERS
- Publication number 20240093158
- Publication date Mar 21, 2024
- Arizona Board of Regents on behalf of Arizona State University
- Douglas Grant MCFADDEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ONCOLYTIC VIRUS COMPRISING IMMUNOMODULATORY TRANSGENES AND USES THE...
- Publication number 20240091284
- Publication date Mar 21, 2024
- Arizona Board of Regents on behalf of Arizona State University
- Douglas Grant McFADDEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COVID-19 VACCINE BASED ON THE MYXOMA VIRUS PLATFORM
- Publication number 20230151387
- Publication date May 18, 2023
- Arizona Board of Regents on behalf of Arizona State University
- Grant MCFADDEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NEW ONCOLYTIC VIRUS PLATFORM TO TREAT CANCERS WITH MYXOMA VIRUS
- Publication number 20230025706
- Publication date Jan 26, 2023
- Oncomyx Therapeutics, Inc.
- Douglas Grant McFADDEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR IMPROVING ONCOLYTIC VIRUS INFECTION FO...
- Publication number 20220296660
- Publication date Sep 22, 2022
- Arizona Board of Regents on behalf of Arizona State University
- Douglas Grant McFADDEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ONCOLYTIC MYXOMA VIRUS EXPRESSING FAST P14 TO TREAT HEMATOLOGICAL C...
- Publication number 20220088096
- Publication date Mar 24, 2022
- ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA, ACTING FOR
- Douglas Grant McFADDEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
A NEW ONCOLYTIC VIRUS PLATFORM TO TREAT CANCERS WITH MYXOMA VIRUS
- Publication number 20210324014
- Publication date Oct 21, 2021
- Arizona Board of Regents on behalf of Arizona State University
- Douglas Grant McFADDEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR IMPROVED POXVIRUS YIELDS
- Publication number 20210301263
- Publication date Sep 30, 2021
- Arizona Board of Regents on behalf of Arizona State University
- Douglas Grant MCFADDEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF TREATING CANCER WITH TNF EXPRESSING MYXOMA VIRUS
- Publication number 20210268050
- Publication date Sep 2, 2021
- Arizona board of regents on behalf of Arizona state university
- Douglas Grant MCFADDEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ONCOLYTIC VIRUS PLATFORM TO TREAT HEMATOLOGICAL CANCER
- Publication number 20210252086
- Publication date Aug 19, 2021
- Arizona Board of Regents on behalf of Arizona State University
- Douglas Grant MCFADDEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEW ONCOLYTIC VIRUS PLATFORM TO TREAT CANCERS WITH MYXOMA VIRUS
- Publication number 20210061864
- Publication date Mar 4, 2021
- Arizona Board of Regents on behalf of Arizona State University
- Douglas Grant McFADDEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF AAV-EXPRESSED M013 PROTEIN AS AN ANTI-INFLAMMATORY THERAPEUTIC
- Publication number 20160376325
- Publication date Dec 29, 2016
- University of Florida Research Foundation, Inc.
- Douglas Grant McFadden
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Mohammed Masmudur Rahman

Person

Patents Grantslast 30 patents

Use of AAV-expressed M013 protein as an anti-inflammatory therapeutic

Oncolytic virus platform to treat cancers with myxoma virus

Patents Applicationslast 30 patents

USE OF AAV-EXPRESSED M013 PROTEIN AS AN ANTI-INFLAMMATORY THERAPEUTIC

ONCOLYTIC VIRUSES THAT EXPRESS MULTI-SPECIFIC IMMUNE CELL ENGAGERS

ONCOLYTIC VIRUS COMPRISING IMMUNOMODULATORY TRANSGENES AND USES THE...

COVID-19 VACCINE BASED ON THE MYXOMA VIRUS PLATFORM

NEW ONCOLYTIC VIRUS PLATFORM TO TREAT CANCERS WITH MYXOMA VIRUS

METHODS AND COMPOSITIONS FOR IMPROVING ONCOLYTIC VIRUS INFECTION FO...

ONCOLYTIC MYXOMA VIRUS EXPRESSING FAST P14 TO TREAT HEMATOLOGICAL C...

A NEW ONCOLYTIC VIRUS PLATFORM TO TREAT CANCERS WITH MYXOMA VIRUS

METHODS FOR IMPROVED POXVIRUS YIELDS

METHODS OF TREATING CANCER WITH TNF EXPRESSING MYXOMA VIRUS

ONCOLYTIC VIRUS PLATFORM TO TREAT HEMATOLOGICAL CANCER

NEW ONCOLYTIC VIRUS PLATFORM TO TREAT CANCERS WITH MYXOMA VIRUS

USE OF AAV-EXPRESSED M013 PROTEIN AS AN ANTI-INFLAMMATORY THERAPEUTIC